Table 2 Insulin management
Overall (n = 408) | Hospitalization < 7 days (n = 199) | Hospitalization ≥ 7 days (n = 209) | P value | |
|---|---|---|---|---|
IV insulin | 282 (69.1) | 136 (68.3) | 146 (69.9) | 0.82 |
Total amount of IV insulin (IU/day) in patient receiving IV insulin (median (IQR)) | 49 [24, 83] | 40 [21, 83] | 56 [30, 82] | 0.027 |
SC insulin | 153 (37.5) | 79 (39.7) | 74 (35.4) | 0.43 |
Short-acting insulin | 133 (32.6) | 74 (37.2) | 59 (28.2) | 0.07 |
Total amount of short-acting insulin (IU/day) in patient receiving SC insulin (median (IQR)) | 12 [8, 25] | 14 [8, 22] | 12 [8, 28] | 0.89 |
Long-acting insulin | 52 (12.7) | 15 (7.5) | 37 (17.7) | 0.003 |
Total amount of long-acting insulin (IU/day) in patient receiving SC insulin (median (IQR)) | 30 [16, 45] | 20 [12, 30] | 30 [18, 68] | 0.017 |
Intermediate insulin | 4 (1.0) | 2 (1.0) | 2 (1.0) | > 0.99 |
Total amount of intermediate insulin (IU/day) in patient receiving SC insulin (median (IQR)) | 37 [32, 49] | 37 [36, 39] | 50 [37, 63] | > 0.99 |
Patients who had previous treatment with IV insulin before SC insulin administration | 60 (39.2) | 21 (26.6) | 39 (52.7) | 0.002 |
IV + SC insulin during the study day | 27 (6.6) | 16 (8.0) | 11 (5.3) | 0.35 |
SC long-acting + short-acting during the study day | 35 (8.6) | 11 (5.5) | 24(11.5) | 0.035 |